Results 71 to 80 of about 922,494 (289)

Fra allmenn inkludering til eksklusiv tilgang?

open access: yesTidsskrift for Samfunnsforskning, 2011
Flere studier har påpekt at det har skjedd store endringer i forholdet mellom stat, n¾ringsliv og organisasjoner i Norge i perioden etter 1980 - endringer fra et korporatistisk system til et system med pluralistiske innslag. Med dette som utgangspunkt er
Trond Løyning
doaj   +1 more source

Building corporate reputation through corporate governance [PDF]

open access: yesManagement, 2008
The authors of the article deal with mutual relations of corporate governance and corporate reputation. The aim of this paper is to show that corporate governance design is in the function of better corporate reputation and to test the perceived relation between corporate governance and corporate reputation.
Cedomir Ljubojevic, Gordana Ljubojevic
openaire   +2 more sources

Glycosylated LGALS3BP is highly secreted by bladder cancer cells and represents a novel urinary disease biomarker

open access: yesMolecular Oncology, EarlyView.
Urinary LGALS3BP is elevated in bladder cancer patients compared to healthy controls as detected by the 1959 antibody–based ELISA. The antibody shows enhanced reactivity to the high‐mannose glycosylated variant secreted by cancer cells treated with kifunensine (KIF).
Asia Pece   +18 more
wiley   +1 more source

La financiarización de los bienes raíces

open access: yesRevista INVI, 2021
Manuel B. Aalbers   +2 more
doaj   +1 more source

THE ROLE OF THE ARCTIC RESOURCE CORPORATIONS IN INNOVATION PROCESSES AND SUBSTITUTION

open access: yesМодернизация, инновация, развитие, 2016
The study is particularly mining companies located in the Russian Arctic. The main results of the study include the rationale for the demand for products Arctic mineral corporations and retain their capitalization, even in conditions of «sanctions ...
V. Selin, V. Tsukerman
doaj   +1 more source

Class IIa HDACs forced degradation allows resensitization of oxaliplatin‐resistant FBXW7‐mutated colorectal cancer

open access: yesMolecular Oncology, EarlyView.
HDAC4 is degraded by the E3 ligase FBXW7. In colorectal cancer, FBXW7 mutations prevent HDAC4 degradation, leading to oxaliplatin resistance. Forced degradation of HDAC4 using a PROTAC compound restores drug sensitivity by resetting the super‐enhancer landscape, reprogramming the epigenetic state of FBXW7‐mutated cells to resemble oxaliplatin ...
Vanessa Tolotto   +13 more
wiley   +1 more source

Towards dealing with multinationals [PDF]

open access: yes, 2018
Paper on dealing with multinational corporations as a key strategy for escaping Africa's ...
Seidman, Ann
core  

PARP inhibition and pharmacological ascorbate demonstrate synergy in castration‐resistant prostate cancer

open access: yesMolecular Oncology, EarlyView.
Pharmacologic ascorbate (vitamin C) increases ROS, disrupts cellular metabolism, and induces DNA damage in CRPC cells. These effects sensitize tumors to PARP inhibition, producing synergistic growth suppression with olaparib in vitro and significantly delayed tumor progression in vivo. Pyruvate rescue confirms ROS‐dependent activity.
Nicolas Gordon   +13 more
wiley   +1 more source

Sources of Legal Regulation of Mergers, Acquisitions, Consolidations, Joint Stock Companies in Russia and Corporations in the United States

open access: yesVestnik MGIMO-Universiteta, 2015
The article outlines general characteristics of the sources of law, regulating relations associated with mergers, consolidations, acquisitions of joint stock companies in Russia and corporations in the United States respectively in the Russian ...
Stanislav E. Kuzmin
doaj  

Global Retailing: An American Business? [PDF]

open access: yesOvidius University Annals: Economic Sciences Series, 2020
Since the end of the Second World War, retail has undergone a profound and long-term transformation all over the world. The second half of the twentieth century witnessed a structural shift from small and independent single-establishment retailers ...
Sorin-George Toma, Grădinaru Cătălin
doaj  

Home - About - Disclaimer - Privacy